ClinicalTrials.gg
RecruitingNCT07643311Updated Jun 11, 2026

Milled vs 3D-Printed Partial-Coverage Restorations in Endodontically Treated Molars

An interventional study of Milled Composite Resin Onlay/Overlay Restoration and 3D-Printed Composite Resin Onlay/Overlay Restoration in Endodontically Treated Teeth, sponsored by Hospital San Jose. Recruiting at 1 site in Chile. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-06-11.

Sponsored by Hospital San Jose · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started May 2026; still recruiting 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
142
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The goal of this clinical trial is to compare the clinical performance of Computer-Aided Design and Computer-Aided Manufacturing (CAD/CAM)-milled and 3D-printed composite resin partial-coverage restorations in endodontically treated molars.

The main questions it aims to answer are:

  • Do 3D-printed composite resin partial-coverage restorations show similar clinical performance compared with CAD/CAM-milled composite resin restorations?
  • Are there differences in survival, success rates, and complications between the two types of restorations over a 3-year follow-up period?

Researchers will compare CAD/CAM-milled composite resin restorations with 3D-printed composite resin restorations to evaluate their clinical performance.

Participants will:

  • Receive a partial-coverage restoration (onlay or overlay) in an endodontically treated molar.
  • Be randomly assigned to receive either a CAD/CAM-milled or a 3D-printed composite resin restoration.
  • Attend follow-up visits at 12, 24, and 36 months.
  • Undergo clinical evaluations by two blinded evaluators using the revised FDI criteria and standardized photographic documentation.
Read the detailed description

This randomized controlled clinical trial evaluates the clinical performance of indirect composite resin partial-coverage restorations fabricated using subtractive and additive manufacturing technologies in endodontically treated molars.

The study investigates whether 3D-printed composite resin restorations can achieve clinical outcomes comparable to CAD/CAM-milled composite resin restorations when used for cuspal coverage of structurally compromised posterior teeth.

All restorations will be fabricated using a fully digital workflow. Tooth preparation, immediate dentin sealing, digital intraoral scanning, restoration fabrication, and adhesive cementation procedures will be standardized and performed according to a predefined clinical protocol.

The trial will be conducted at Hospital San José, Santiago, Chile, using commercially available restorative materials manufactured by subtractive and additive technologies. Clinical performance will be evaluated according to internationally accepted restorative assessment criteria.

The study aims to generate medium-term clinical evidence regarding the use of 3D-printed composite resin restorations as a potential alternative to conventional CAD/CAM-milled restorations in restorative dentistry.

02

Conditions studied

  • Endodontically Treated Teeth

Browse trials for

Keywords

  • Onlay
  • Overlay
  • Milled Composite Resin
  • 3D-Printed Composite Resin
  • partial coverage restoration
  • CAD/CAM
  • 3D printing
  • Indirect restoration
  • FDI Criteria
03

In context

Tooth, Nonvital

111 studies on the registry are indexed under Tooth, Nonvital; 18 are open to participants now.

This study's planned enrollment of 142 is above the median of 50 across 101 interventional studies indexed under Tooth, Nonvital.

Browse Tooth, Nonvital studies →

Lead sponsor

This is the only study on the registry with Hospital San Jose as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 to 70 years
  • Absence of active periodontal disease
  • Good oral hygiene (O'Leary plaque index \<20%)
  • Absence of parafunctional habits (e.g., bruxism, onychophagia)
  • Endodontically treated first molars (maxillary or mandibular) with extensive Class II cavities and loss of at least one cusp, requiring onlay or overlay restoration
  • Tooth with functional occlusal contact and at least one proximal contact
  • Referred from the Endodontics Department of Hospital San José, with endodontic treatment completed at the same institution
  • Ability to provide written
  • Ability to attend follow-up visits at 12, 24, and 36 months

Exclusion criteria

Exclusion Criteria:

  • Untreated active periodontal disease
  • Poor oral hygiene (O'Leary plaque index ≥20%)
  • Generalized active caries
  • Active parafunctional habits
  • Teeth with complete circumferential structural destruction or insufficient coronal tooth structure for onlay/overlay restoration
  • Subgingival margins compromising the biologic width
  • Known allergy to study materials
  • Pregnancy or breastfeeding
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
142 participants (estimated)

Study arms

  • Active comparator
    Milled Composite Resin Onlay/Overlay

    Participants receive indirect onlay or overlay restorations fabricated from milled composite resin blocks (HC Block, Shofu, Japan) for the rehabilitation of endodontically treated molars with extensive loss of tooth structure. Tooth preparation, immediate dentin sealing, digital impression, and adhesive cementation procedures are standardized for all participants

    Device: Milled Composite Resin Onlay/Overlay Restoration

  • Experimental
    3D-Printed Composite Resin Onlay/Overlay

    Participants receive indirect onlay or overlay restorations fabricated from 3D-printed composite resin (Rodin Sculpture, Pac-Dent, USA) for the rehabilitation of endodontically treated molars with extensive loss of tooth structure. Tooth preparation, immediate dentin sealing, digital impression, and adhesive cementation procedures are standardized for all participants.

    Device: 3D-Printed Composite Resin Onlay/Overlay Restoration

Interventions

  • DeviceMilled Composite Resin Onlay/Overlay Restoration

    Indirect partial coverage restoration fabricated from milled composite resin blocks (HC Block, Shofu, Japan) and adhesively cemented on endodontically treated molars.

  • Device3D-Printed Composite Resin Onlay/Overlay Restoration

    Indirect partial coverage restoration fabricated from 3D-printed composite resin (Rodin Sculpture, Pac-Dent, USA) and adhesively cemented on endodontically treated molars.

06

What researchers measure

Primary outcomes

  1. Clinical performance of onlay and overlay restorations according to revised World Dental Federation (FDI) criteria.

    Clinical performance of milled and 3D-printed composite resin onlay and overlay restorations assessed using the revised FDI criteria. An overall FDI evaluation score will be assigned to each restoration by two blinded evaluators.

    Time frame: Baseline, 12 months, 24 months, and 36 months (primary endpoint at 36 months)

Secondary outcomes

  1. Restoration survival rate

    Survival of milled and 3D-printed composite resin onlay and overlay restorations. A restoration will be considered surviving if it remains in function at follow-up, regardless of the need for minor repair.

    Time frame: 36 months

  2. Restoration success rate

    Success of restorations according to revised FDI criteria. Restorations receiving clinically acceptable ratings and not requiring corrective intervention will be considered successful.

    Time frame: 36 months

  3. Restoration failure rate

    Proportion of restorations requiring replacement during the 36-month follow-up period.

    Time frame: 36 months

  4. Clinical complications

    Frequency and type of clinical complications observed during the 36-month follow-up period, including mechanical, biological, and esthetic complications associated with the restorations.

    Time frame: Baseline to 36 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared with other researchers due to confidentiality and privacy considerations related to patient information.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07643311
Lead sponsor
Hospital San Jose
Responsible party
Tomás Yoma Galleguillos (Principal Investigator, Department of Dentistry, Hospital San Jose, Hospital San Jose) — Principal investigator
First posted
Jun 11, 2026
Start date
May 29, 2026
Primary completion
May 31, 2030 (estimated)
Completion
Jun 30, 2030 (estimated)
Last update
Jun 11, 2026

Study contacts

Tomás Yoma Galleguillos, DDS
Contact
tomasyoma@gmail.com
+56985768407
Tomás Yoma Galleguillos, DDS
principal investigator · Hospital San José, Santiago, Chile

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion